By:
On:
In: Poor company, Stock analysis
Tagged:
With: 0 Comments

 

Company name RadNet Inc.
Stock ticker RDNT
Live stock price [stckqut]RDNT[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Poor
Sales growth Fair
EPS growth Good
P/E growth Poor
EBIT growth Poor

ANALYSIS

Confident Investor Rating Poor
Target stock price (TWCA growth scenario) $2.92
Target stock price (averages with growth) $0.19
Target stock price (averages with no growth) $0.19
Target stock price (manual assumptions) $1.88

The following company description is from Google Finance: http://www.google.com/finance?q=rdnt

RadNet, Inc. (RadNet) is engaged in providing freestanding, fixed-site outpatient diagnostic imaging services in the United States. The Company’s services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. On November 7, 2011, the Company completed the acquisition of all outstanding equity interests in Raven Holdings U.S., Inc. In November 2011, the Company acquired 21 imaging facilities in Maryland, Delaware and Rhode Island, consisting of the majority of the United States imaging operations of CML HealthCare Inc. (CML). On August 1, 2011, the Company completed the acquisition of a multi-modality imaging center located in San Jacinto, California from San Jacinto Imaging, LLC. On February 18, 2011, the Company completed the acquisition of Team Radiology, Inc. On December 31, 2012, it acquired Lenox Hill Radiology.

 

Confident Investor comments: At this price and at this time, I do not think that a Confident Investor can confidently invest in RadNet Inc.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(s2member_level1)]
In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

Stock price at the time of the calculation: $1.9

Growth: 0.1

Current EPS (TTM): $1.34

P/E: 1.4

Future EPS Calc: $2.15

Future Stock Price Calc: $3.02

Target stock price: $1.87

I hope that this makes you a better investor. [/s2If]

By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments

Company name St. Jude Medical, Inc.
Stock ticker STJ
Live stock price [stckqut]STJ[/stckqut]
P/E compared to competitors Fair

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Poor
EPS growth Fair
P/E growth Good
EBIT growth Poor

ANALYSIS

Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $65.79
Target stock price (averages with growth) $80.45
Target stock price (averages with no growth) $71.36
Target stock price (manual assumptions) $67.23

The following company description is from Google Finance: http://www.google.com/finance?q=stj

St. Jude Medical, Inc. (St. Jude) develops, manufactures and distributes cardiovascular medical devices. Its principal products in each therapy area are: Cardiac Rhythm Management – tachycardia implantable cardioverter defibrillator systems (ICDs) and bradycardia pacemaker systems (pacemakers); Cardiovascular – vascular products, which include vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, vascular plugs and other vascular accessories, and structural heart products, which include heart valve replacement and repair products and structural heart defect devices; Atrial Fibrillation – electrophysiology (EP) introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems, and Neuromodulation – neurostimulation products, which include spinal cord and deep brain stimulation devices. In August 2013, St. Jude Medical Inc announced the acquisition of Endosense SA.

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in St. Jude Medical, Inc. as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(s2member_level1)]
In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

Stock price at the time of the calculation: $67.02

Growth: 0.1

Current EPS (TTM): $2.49

P/E: 27

Future EPS Calc: $4.01

Future Stock Price Calc: $108.27

Target stock price: $67.23

I hope that this makes you a better investor. [/s2If]

By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments

Company name Thoratec Corporation
Stock ticker THOR
Live stock price [stckqut]THOR[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Poor
EPS growth Good
P/E growth Poor
EBIT growth Good

ANALYSIS

Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $58.3
Target stock price (averages with growth) $125.68
Target stock price (averages with no growth) $143.09
Target stock price (manual assumptions) $45.19

The following company description is from Google Finance: https://www.google.com/finance?q=NASDAQ%3ATHOR&sq=thor&sp=2&ei=hskQU7DvKYWxqgHHlQE 

Thoratec Corporation is engaged in mechanical circulatory support with a product portfolio to treat the range of clinical needs for advanced heart failure (HF) patients. The Company develops, manufactures and markets medical devices used for circulatory support. For advanced HF, its primary product lines are its ventricular assist devices (VADs), which include the Thoratec Paracorporeal Ventricular Assist Device (PVAD), the Thoratec Implantable Ventricular Assist Device (IVAD), the HeartMate Left Ventricular Assist System (HeartMate XVE), and the HeartMate II Left Ventricular Assist System (HeartMate II). For acute HF, its product lines are the CentriMag Acute Circulatory System (CentriMag) and for pediatric patients the PediMag/PediVAS Acute Circulatory System (PediMag/PediVAS). On August 3, 2011, the Company acquired Levitronix LLC (Levitronix). During the year ended December 31, 2011, the Company discontinued the sale of the HeartMate XVE.

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in Thoratec Corporation as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(s2member_level1)]
In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

Stock price at the time of the calculation: $37.76

Growth: 0.14

Current EPS (TTM): $1.26

P/E: 30

Future EPS Calc: $2.42

Future Stock Price Calc: $72.78

Target stock price: $45.19

I hope that this makes you a better investor. [/s2If]

By:
On:
In: Good company, Stock analysis
Tagged:
With: 0 Comments

Company name Whole Foods Market, Inc.
Stock ticker WFM
Live stock price [stckqut]WFM[/stckqut]
P/E compared to competitors Fair

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Fair
EPS growth Good
P/E growth Fair
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $64.43
Target stock price (averages with growth) $90.86
Target stock price (averages with no growth) $75.85
Target stock price (manual assumptions) $64.56

The following company description is from Google Finance: http://www.google.com/finance?q=wfm

Whole Foods Market, Inc. (Whole Foods Market), is a retailer of natural and organic foods. The Company operates in one segment: natural and organic foods supermarkets. As of September 29, 2013, it operated 362 stores in the United States, Canada, and the United Kingdom. The Company’s stores average 38,000 square feet in size and are supported by its Austin headquarters, regional offices, distribution centers, bakehouse facilities, commissary kitchens, seafood-processing facilities, meat and produce procurement centers, and a specialty coffee and tea procurement and roasting operation. In February 2014, Whole Foods Market Inc acquired leases from Safeway Inc for seven locations formerly operated as Dominick’s stores.

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in Whole Foods Market, Inc.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(s2member_level1)]
In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

Stock price at the time of the calculation: $53.92

Growth: 0.14

Current EPS (TTM): $1.5

P/E: 36

Future EPS Calc: $2.88

Future Stock Price Calc: $103.97

Target stock price: $64.55

I hope that this makes you a better investor. [/s2If]